Montefiore Einstein Comprehensive Cancer Center Unveils New Institute
Renowned immunologist, Xingxing Zang, Ph.D., has been appointed as the first director of the newly launched Katz Institute for Immunotherapy for Cancer and Inflammatory Disorders at the Montefiore Einstein Comprehensive Cancer Center (MECCC). This cutting-edge institute's goal is to propel immunotherapy technologies into clinical trials and to develop effective treatments for cancer.
Leading the Way in Immunotherapy
Dr. Zang, a well-respected expert in innovative immunotherapy, shared his excitement about taking the lead on this project. He envisions fostering a collaborative atmosphere where more than 45 dedicated scientists and clinicians can work together across various fields. This teamwork is intended to uncover new targets for immunotherapy and incorporate fresh approaches into drug development.
The Progression of Immunotherapy
Immunotherapy has significantly changed the field of cancer treatment recently. By leveraging the body’s own immune system, these therapies have become essential in tackling various cancers. For example, adoptive cell therapy involves taking a patient’s immune cells, modifying them, and using them to fight their unique cancers. Additionally, cancer vaccines are designed to train the immune system to identify and attack existing tumors.
Leading-Edge Innovations
Dr. Zang's influential research has led to the discovery of several new immune checkpoints and the development of multiple checkpoint inhibitors, which play a crucial role in boosting immune responses against cancer. His commitment to advancing the field is reflected in ongoing clinical trials evaluating the effectiveness of these inhibitors across different cancer types.
Notable Contributions to Cancer Research
At MECCC, Dr. Zang’s research team is making significant advancements in CAR-T therapy, a specific type of adoptive cell therapy primarily aimed at blood cancers. Recent findings indicate that CAR-T therapy may also show promise against solid tumors, highlighting the potential for wider applications of immunotherapy.
Essential Philanthropic Support
The launch of the Katz Institute was made possible thanks to critical philanthropic support. A generous endowment gift of $4.5 million from Marilyn and Stanley Katz provides a solid funding foundation to sustain ongoing research efforts.
Leadership Committed to Excellence
Edward Chu, M.D., the director of MECCC, commended Dr. Zang’s leadership, noting that his expertise and collaborative nature are vital for moving the institute towards its ambitious objectives. With a strong focus on transforming cancer care, the institute is set to emerge as a leader in immunotherapy.
About the Montefiore Einstein Comprehensive Cancer Center
MECCC is a comprehensive cancer center designated by the National Cancer Institute, emphasizing interdisciplinary research and patient-centered care. Situated in a diverse community, MECCC is committed to lessening the impact of cancer, particularly among underrepresented groups. Since its establishment in 1971, the center has been at the forefront of cancer research, clinical care, and community engagement.
Frequently Asked Questions
What is the primary goal of the Katz Institute?
The Katz Institute seeks to create groundbreaking immunotherapy technologies and convert them into effective treatments for cancer through collaborative research efforts.
Who is in charge of the new immunotherapy institute?
Xingxing Zang, Ph.D., a distinguished immunologist, has been named the inaugural director of the Katz Institute.
What areas of immunotherapy are Dr. Zang focusing on?
Dr. Zang has expertise in several immunotherapy methods, including checkpoint inhibitors and CAR-T therapies that enhance the body’s immune response to cancer.
How is the Katz Institute financed?
The institute receives funding from philanthropic contributions, particularly the $4.5 million endowment provided by Marilyn and Stanley Katz, which supports ongoing research efforts.
What is the mission statement of the Montefiore Einstein Comprehensive Cancer Center?
MECCC's mission revolves around excelling in cancer research, clinical care, and education, while actively working to ease cancer’s burden on diverse communities.
